Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers
Status:
Completed
Trial end date:
2017-10-30
Target enrollment:
Participant gender:
Summary
This is a phase 1, open-label, randomized, single dose, crossover clinical trial to assess
the effect of food on the pharmacokinetics of YHD1119 in healthy male volunteers.
Hypothesis: "YHD1119" is showing equal equal pharmacokinetics in fasted and fed state.